JENNIFER GILTNER: Open Payments
NPI 1336746569 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 48 payments from 12 companies in 2025. Trend: 2023 $444 · 2024 $439 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $196 |
| ABBVIE INC. | 6 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $50 |
| Abbott Laboratories | 1 | $19 |
| Edwards Lifesciences Corporation | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: NURTEC ODT, LEQVIO, GEMTESA, QULIPTA, MOUNJARO, ELIQUIS, UBRELVY, JARDIANCE.
Industry payments across MO — which companies pay providers there.
